AbL Diagnostics SA (ABLD) - Total Liabilities

Latest as of December 2025: €5.32 Million EUR ≈ $6.22 Million USD

Based on the latest financial reports, AbL Diagnostics SA (ABLD) has total liabilities worth €5.32 Million EUR (≈ $6.22 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check AbL Diagnostics SA (ABLD) asset resilience to evaluate the company's liquid asset resilience ratio.

AbL Diagnostics SA - Total Liabilities Trend (2007–2025)

This chart illustrates how AbL Diagnostics SA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is AbL Diagnostics SA's balance sheet.

AbL Diagnostics SA Competitors by Total Liabilities

The table below lists competitors of AbL Diagnostics SA ranked by their total liabilities.

Company	Country	Total Liabilities
Bizim Toptan Satis Magazalari AS IS:BIZIM	Turkey	TL11.77 Billion
Rosebank Industries PLC LSE:ROSE	UK	GBX1.09 Billion
Augwind Energy Tech Storage Ltd TA:AUGN	Israel	ILA12.86 Million
Shriro Holdings Ltd AU:SHM	Australia	AU$26.61 Million
Derluks Yatirim Holding AS IS:DERHL	Turkey	TL3.29 Billion
Song Ho Industrial Co Ltd TWO:5016	Taiwan	NT$999.69 Million
Kinatico Ltd AU:KYP	Australia	AU$6.19 Million

Liability Composition Analysis (2007–2025)

This chart breaks down AbL Diagnostics SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of AbL Diagnostics SA to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.41	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.70	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.41	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AbL Diagnostics SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AbL Diagnostics SA (2007–2025)

The table below shows the annual total liabilities of AbL Diagnostics SA from 2007 to 2025.

Year	Total Liabilities	Change
2025-12-31	€5.32 Million ≈ $6.22 Million	+23.11%
2024-12-31	€4.32 Million ≈ $5.05 Million	-46.86%
2023-12-31	€8.14 Million ≈ $9.51 Million	-5.99%
2022-12-31	€8.65 Million ≈ $10.12 Million	+9081.14%
2021-12-31	€94.26K ≈ $110.20K	+420.78%
2020-12-31	€18.10K ≈ $21.16K	-84.70%
2019-12-31	€118.31K ≈ $138.32K	-80.07%
2018-12-31	€593.64K ≈ $694.03K	+346.04%
2017-12-31	€133.09K ≈ $155.60K	-17.93%
2016-12-31	€162.18K ≈ $189.60K	-79.83%
2015-12-31	€804.11K ≈ $940.09K	+460.64%
2014-12-31	€143.43K ≈ $167.68K	-34.43%
2013-12-31	€218.75K ≈ $255.74K	+151.83%
2012-12-31	€86.86K ≈ $101.55K	-21.84%
2011-12-31	€111.14K ≈ $129.94K	+2.38%
2010-12-31	€108.56K ≈ $126.91K	+90.10%
2009-12-31	€57.10K ≈ $66.76K	+12.32%
2008-12-31	€50.84K ≈ $59.44K	-1.20%
2007-12-31	€51.46K ≈ $60.16K	--

About AbL Diagnostics SA

PA:ABLD France Health Information Services

Market Cap

$45.84 Million

€39.21 Million EUR

Market Cap Rank

#22958 Global

#355 in France

Share Price

€2.44

Change (1 day)

-5.43%

52-Week Range

€2.20 - €4.60

All Time High

€16.08